Postprandial blood glucose ( 9.270.4 versus 10.10.4 mmol/L ; p = 0.001 ) and HbA1c ( 6.840.15 ( 511.6 ) versus 7.100.17 % ( 541.9 mmol/mol ) ; p < 0.001 ) were significantly reduced with saxagliptin treatment compared to placebo .